Drawing for PANGAEA

USPTO serial 90314624

PANGAEA

Reviewed by CopyMark Law Group

Reg. 6868669Status 700Registered
Filing date
Status date
Registration date
Oct 11, 2022
Examiner
PERRY, KIMBERLY B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PANGAEA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard S. Finkelstein

Richard S. Finkelstein RC TRADEMARK COMPANY, LLCP.O. BOX 940BROOKFIELD, CT 06804UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software for data intelligence extraction from structured and unstructured data in the field of healthcare; Downloadable software for data intelligence extraction from structured and unstructured data in the field of biotechnology; Downloadable software for data intelligence extraction from structured and unstructured data in the field of pharmaceuticals; Downloadable software for modelling of data related to human phenotype; Downloadable software for modelling of data related to clinical features of humans; Downloadable software for monitoring, tracking and analysing electronic health records (EHRs) and annotation of phenotypic abnormalities; Downloadable software for analysis of clinical patient information and human clinical features in the field of healthcare; Downloadable software for conducting experiments and clinical trials; Downloadable software for the management of electronic health records; Downloadable software for the processing of phenotypic data; Downloadable software for the processing of clinical patient information and human clinical features; Downloadable computer search engine software; Downloadable enterprise software in the nature of a database for non-transactional data and a search engine for database content; Downloadable artificial intelligence software for the processing of health and clinical data gathered from structured and unstructured electronic health records for the purpose modelling of data related to health of individuals; Downloadable software for the extraction, collection, processing and summarising of data in the field of healthcare; Downloadable software for the extraction, collection, processing and summarising of data in the field of biotechnology; Downloadable software for the extraction, collection, processing and summarising of data in the field of pharmaceuticalsACTIVEAug 27, 2020
042Software as a Service for data intelligence extraction from structured and unstructured data in the field of healthcare; Software as a Service for data intelligence extraction from structured and unstructured data in the field of biotechnology; Software as a Service for data intelligence extraction from structured and unstructured data in the field of pharmaceuticals; Software as a Service for modelling of data related to human phenotype; Software as a Service for modelling of data related to clinical patient information and human clinical features; Software as a Service for monitoring, tracking and analysing electronic health records (EHRs) and annotation of phenotypic abnormalities; Software as a Service for analysis of clinical characteristics in the field of healthcare; Software as a Service for conducting experiments and clinical trials; Software as a Service for the management of electronic health records; Software as a Service for the processing of phenotypic data; Software as a Service for the processing of data related to clinical patient information and human clinical features; Research in the field of artificial intelligence and deep learning; Software development in the field of healthcare; Scientific study and research in the field of healthcare; Providing a website featuring a search engine for phenotype characteristics searching; Providing a website featuring a search engine for data related to clinical patient information and human clinical features; Computer services, namely, providing search engines for obtaining information about phenotypes on a global computer network; Maintenance of on-line databases for others in the field of healthcare; Software as a Service for the extraction, collection, processing and summarising of data in the field of healthcare; Software as a Service for the extraction, collection, processing and summarising of data in the field of biotechnology; Software as a Service for the extraction, collection, processing and summarising of data in the field of pharmaceuticals; Scientific research consulting in relation to all of the aforementioned services; Consulting services in relation to all of the aforementioned servicesACTIVEAug 27, 2020
044Bio-surveillance tracking and monitoring services for medical diagnosis and treatment purposes; providing medical services using healthcare predictive analytics; providing medical services using hospital decision support systems; healthcare process modeling for medical diagnosis and treatment purposes; processing and analyzing HL7 data for medical diagnosis, health risk management and treatment purposes; natural language processing for patient data for medical diagnosis and treatment purposes; healthcare services, namely, remote monitoring and tracking of data indicative of the health or condition of an individual or a group of individuals for medical diagnosis and treatment purposesACTIVEAug 27, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 26, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 26, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 6, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jun 17, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 10, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 3, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 21, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 8, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 2, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 1, 2021ALIEASSIGNED TO LIE—
Oct 27, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2021DOCKASSIGNED TO EXAMINER—
Jan 13, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance